Breakthrough Therapy

A designation made by the U.S. Food and Drug Administration that expedites the review process for new drug therapies for serious medical conditions after initial clinical evidence is submitted to the FDA and shows that the new drug therapy may demonstrate substantial improvement over other available therapies.

Was this helpful? Share it!